Efficacy and Safety of Ramucirumab in Patients with Unresectable Hepatocellular Carcinoma with Progression after Treatment with Lenvatinib.
Kasuya K, Kawamura Y, Kobayashi M, Shindoh J, Kobayashi Y, Kajiwara A, Iritani S, Fujiyama S, Hosaka T, Saitoh S, Sezaki H, Akuta N, Suzuki F, Suzuki Y, Ikeda K, Arase Y, Eguchi Y, Hashimoto M, Kumada H.
Kasuya K, et al. Among authors: arase y.
Intern Med. 2021 Feb 1;60(3):345-351. doi: 10.2169/internalmedicine.5185-20. Epub 2020 Sep 19.
Intern Med. 2021.
PMID: 32963154
Free PMC article.